LYS.PA
Price:
$0.2795
Market Cap:
$4.95M
Lysogene S.A., a biopharmaceutical gene therapy company, focuses on the discovery and development of therapies for children with neurodegenerative lysosomal storage disorders. Its clinical programs include LYS-SAF302, which is in Phase II/III clinical trial for the treatment of mucopolysaccharidosis type IIIA; and LYS-GM101 that is in Phase I/II trial for the treatment of GM1 gangliosidosis. The company has a collaborative research collaboration with the Weizmann Institute of Science for developing a novel AAV gene therapy approach for neuronopathic gaucher disease, parkinson disease, and other diseases. Lysogene S.A. was incorporated in 2009 and is based in Neuilly-sur-Seine, France.
Industry
Biotechnology
IPO Date
2017-02-08
Stock Exchange
EURONEXT
Ticker
LYS.PA
According to Lysogene S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.64. This represents a change of -Infinity% compared to the average of 0 of the last 4 quarters.
The mean historical PE Ratio of Lysogene S.A. over the last ten years is -17.12. The current -0.64 PE Ratio has changed 271.09% with respect to the historical average. Over the past ten years (40 quarters), LYS.PA's PE Ratio was at its highest in in the December 2019 quarter at 0. The PE Ratio was at its lowest in in the January 2014 quarter at -87.95.
Average
-17.12
Median
-7.64
Minimum
-89.20
Maximum
-1.84
Discovering the peaks and valleys of Lysogene S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 285.85%
Maximum Annual PE Ratio = -1.84
Minimum Annual Increase = -83.23%
Minimum Annual PE Ratio = -89.20
Year | PE Ratio | Change |
---|---|---|
2021 | -2.36 | -71.23% |
2020 | -8.20 | 15.71% |
2019 | -7.09 | 285.85% |
2018 | -1.84 | -20.33% |
2017 | -2.31 | -79.02% |
2016 | -10.99 | -26.52% |
2015 | -14.96 | -83.23% |
The current PE Ratio of Lysogene S.A. (LYS.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.88
5-year avg
-4.36
10-year avg
-17.12
Lysogene S.A.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lysogene S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lysogene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lysogene S.A.'s PE Ratio?
How is the PE Ratio calculated for Lysogene S.A. (LYS.PA)?
What is the highest PE Ratio for Lysogene S.A. (LYS.PA)?
What is the 3-year average PE Ratio for Lysogene S.A. (LYS.PA)?
What is the 5-year average PE Ratio for Lysogene S.A. (LYS.PA)?
How does the current PE Ratio for Lysogene S.A. (LYS.PA) compare to its historical average?